Evidence map›Paper›PMID 38234869›Full record

ArticleRSC advances2024

Chalcone derivatives' interaction with human serum albumin and cyclooxygenase-2.

Subramani Karthikeyan, Ayyavu Thirunarayanan, Leon Bernet Shano, Arasappan Hemamalini, Anandh Sundaramoorthy, Rajendiran Mangaiyarkarasi, Norhidayah Abu, Singaravelu Ganesan, Shanmugavel Chinnathambi, Ganesh N Pandian

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Subramani KarthikeyanCentre for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology Chennai 600 127 India s.karthikeyan@vit.ac.in.
Ayyavu ThirunarayananDepartment of Chemical Engineering Biotechnology and Materials, FCFM, University of Chile Av. Beauchef 851 Santiago Chile.
Leon Bernet ShanoDivision of Physics, School of Advanced Sciences, Vellore Insititute of Technology (VIT) Chennai Campus Vandalur-Kelambakkam Road Tamil Nadu 600127 India.
Arasappan HemamaliniDepartment of Chemistry, Government College of Engineering Srirangam Sethurapatti Thiruchirappalli Tamil Nadu India.
Anandh SundaramoorthyDepartment of Medical Physics, Anna University Chennai-600 025 India.
Rajendiran MangaiyarkarasiCentre for Nanotechnology Research, Vellore Institute of Technology Vellore Tamil Nadu India.
Norhidayah AbuDepartment of Medical Microbiology & Parasitology, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian 16150 Kelantan Malaysia.ORCID https://orcid.org/0000-0001-6369-7368
Singaravelu GanesanDepartment of Medical Physics, Anna University Chennai-600 025 India.
Shanmugavel ChinnathambiInstitute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University Kyoto 616-8510 Japan chinnathambi.shanmugavel.8s@kyoto-u.ac.jp namasivayam.ganeshpandian.5z@kyoto-u.ac.jp.ORCID https://orcid.org/0000-0001-9550-5367
Ganesh N PandianInstitute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University Kyoto 616-8510 Japan chinnathambi.shanmugavel.8s@kyoto-u.ac.jp namasivayam.ganeshpandian.5z@kyoto-u.ac.jp.
Vellore Institute of Technology University · INAnna University, Chennai · INKyoto University · JPUniversiti Sains Malaysia · MYUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chalcone derivatives are an extremely valuable class of compounds, primarily due to the keto-ethylenic group, CO-CH[double bond, length as m-dash]CH-, they contain. Moreover, the presence of a reactive α,β-unsaturated carbonyl group confers upon them a broad range of pharmacological properties. Recent developments in heterocyclic chemistry have led to the synthesis of chalcone derivatives, which have been biologically investigated for their activity against certain diseases. In this study, we investigated the binding of new chalcone derivatives with COX-2 (cyclooxygenase-2) and HSA (Human Serum Albumin) using spectroscopic and molecular modeling studies. COX-2 is commonly found in cancer and plays a role in the production of prostaglandin E (2), which can help tumors grow by binding to receptors. HSA is the most abundant protein in blood plasma, and it transports various compounds, including hormones and fatty acids. The conformation of chalcone derivatives in the HSA complex system was established through fluorescence steady and excited state spectroscopy techniques and FTIR analyses. To gain a more comprehensive understanding, molecular docking, and dynamics were conducted on the target protein (COX-2) and transport protein (HSA). In addition, we conducted density-functional theory (DFT) and single-point DFT to understand intermolecular interaction in protein active sites.

Identifiers

PMID38234869
PMCPMC10792617
OpenAlexW4390947060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.